Search results
Salman Khan Watch Price: Did you spot Salman Khan's swanky Rs 20.87 Crore watch? | - Times of India
The Times of India· 11 hours agoFor the celebrations, Salman arrived in a simple all-black kurta pyjama suit with gelled-back hair...
Markets sink below record levels; Sensex tanks over 400 points on widespread profit booking
Indian Express· 32 minutes agoThe 30-share BSE Sensex opened 129.72 points higher to hit a fresh all-time high of 80,481.36. It...
Top Gainers and Losers today on 10 July, 2024: Asian Paints, SBI Life Insurance Company, Mahindra &...
Livemint· 2 hours agoTop Gainers and Losers Today : The Sensex lost 426.87 points, or -0.53, to settle at 80351.64, while...
RVNL secures ₹202.87 crore project from South Eastern Railway - CNBC TV18
CNBC TV18· 1 day agoThe project is in the Kharagpur division and aims to support the railway's capacity to handle 3000...
Stock market update: Fertilisers stocks down as market falls
The Economic Times· 52 minutes agoThe 30-share BSE Sensex closed down 426.87 points at 79924.77
Anant Ambani-Radhika Merchant Wedding: Did Salman Khan's Watch Cost Rs 20.87 Crore?
Times Now· 7 hours agoSalman Khan turned heads at the haldi ceremony of Anant Ambani and Radhika Merchant. The actor...
Emcure Pharmaceuticals IPO listing date today. Here’s what GMP, experts say on share debut | Stock...
Livemint· 10 hours agoEmcure Pharmaceuticals IPO: Emcure Pharmaceuticals IPO listing date has been scheduled for today...
Railway stock: 3 reasons why RVNL shares are in focus today
Business Today· 9 hours agoRVNL signed MoU with TATWEER Middle East and Africa LLC for using RVNL’s expertise in railway...
Taylor Swift Sings Her Favorite Songs Including Last Kiss To Mark Her 113th Eras Tour Show
Pinkvilla· 21 minutes agoTaylor Swift's Eras Tour has been running successfully with crowded shows, and it is presently...
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Business Standard India· 7 hours agoAccording to analysts, Emcure Pharma is quoting at a reasonable valuation with a niche opportunity...